Nrc Health (NRC) Current Deferred Revenue (2010 - 2026)

Nrc Health's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $17.2 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 10.87% year-over-year to $17.2 million; the TTM figure through Mar 2026 stood at $17.2 million (up 10.87% YoY), while the FY2025 annual figure was $16.2 million, up 2.63% from the prior year.
• Current Deferred Revenue came in at $17.2 million for Q1 2026 at Nrc Health, up from $16.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $17.8 million in Q3 2025 to a low of $14.5 million in Q2 2024.
• A 5-year average of $16.0 million and a median of $15.8 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue declined 11.71% in 2022 and gained 10.87% in 2026, its largest moves.
• Nrc Health's Current Deferred Revenue stood at $15.2 million in 2022, then declined by 2.4% to $14.8 million in 2023, then increased by 6.42% to $15.8 million in 2024, then grew by 2.63% to $16.2 million in 2025, then climbed by 6.12% to $17.2 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $17.2 million, $16.2 million, and $17.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison